Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2002 | 12-2001 | 09-2001 | 06-2001 | 03-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 988 | 1,653 | 1,937 | 193 | 322 |
| Other current assets | 63 | 0 | 0 | 0 | 251 |
| TOTAL | $1,105 | $1,762 | $2,189 | $455 | $672 |
| Non-Current Assets | |||||
| PPE Net | 151 | 168 | 185 | 196 | 209 |
| Other Non-Current Assets | 11 | 11 | 10 | 10 | 10 |
| TOTAL | $162 | $179 | $195 | $206 | $219 |
| Total Assets | $1,267 | $1,941 | $2,384 | $660 | $890 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 3,350 | N/A | N/A |
| Accounts payable and accrued liabilities | 190 | 167 | 102 | 331 | 136 |
| Accrued Expenses | N/A | 142 | N/A | N/A | N/A |
| TOTAL | $190 | $309 | $3,452 | $831 | $136 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,825 | 1,731 | N/A | N/A | N/A |
| TOTAL | $1,825 | $1,731 | $N/A | $N/A | $N/A |
| Total Liabilities | $2,014 | $2,041 | $3,452 | $831 | $136 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 11,637 | 11,627 | 11,596 | 11,579 | 11,501 |
| Common Shares | 30,661 | 30,602 | 28,949 | 28,944 | 28,748 |
| Retained earnings | -31,502 | -30,795 | -30,111 | -29,208 | -28,088 |
| TOTAL | $-747 | $-99 | $-1,069 | $-170 | $754 |
| Total Liabilities And Equity | $1,267 | $1,941 | $2,384 | $661 | $890 |